Truist Financial Corp Acquires 1,154 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Truist Financial Corp increased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,880 shares of the company’s stock after buying an additional 1,154 shares during the period. Truist Financial Corp owned 0.05% of Acadia Healthcare worth $3,801,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in ACHC. Campbell & CO Investment Adviser LLC raised its holdings in Acadia Healthcare by 177.4% in the 3rd quarter. Campbell & CO Investment Adviser LLC now owns 7,357 shares of the company’s stock valued at $517,000 after acquiring an additional 4,705 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Acadia Healthcare during the fourth quarter worth about $24,157,000. Louisiana State Employees Retirement System acquired a new stake in Acadia Healthcare during the fourth quarter worth about $2,014,000. Phocas Financial Corp. bought a new position in Acadia Healthcare in the 4th quarter valued at about $6,887,000. Finally, Jennison Associates LLC raised its position in shares of Acadia Healthcare by 26.1% in the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock valued at $89,327,000 after buying an additional 238,114 shares in the last quarter.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. UBS Group upped their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research report on Monday, March 4th. TD Cowen increased their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.89.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 2.00% of the company’s stock.

Acadia Healthcare Trading Up 2.5 %

ACHC opened at $67.78 on Tuesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. Acadia Healthcare Company, Inc. has a fifty-two week low of $64.74 and a fifty-two week high of $87.77. The company’s 50 day moving average price is $76.42 and its two-hundred day moving average price is $77.45. The firm has a market capitalization of $6.29 billion, a price-to-earnings ratio of -484.11, a PEG ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. Acadia Healthcare’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.